Clinical Trials Directory

Trials / Completed

CompletedNCT00830713

Vitiligo Skin Transplantation

Safety and Efficacy of Melanocyte-keratinocyte Transplantation in the Treatment of Vitiligo

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Henry Ford Health System · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In vitiligo, the melanocytes are lost from the skin in certain areas. One treatment for vitiligo takes the melanocytes from areas of normal skin and places them on areas of that same person's body which have lost their color. This is called the melanocyte-keratinocyte transplantation procedure (MKTP). This procedure has been used successfully in over 3000 cases in India and Saudi Arabia. The purpose of this study is to see if it is effective when performed at the investigators' institution.

Conditions

Interventions

TypeNameDescription
PROCEDUREMelanocyte-keratinocyte transplantation procedure (MKTP)skin pigment cells are taken from areas of normal skin and placed on areas of that same person's body which have lost their color.

Timeline

Start date
2009-01-01
Primary completion
2011-10-01
Completion
2011-10-01
First posted
2009-01-28
Last updated
2012-09-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00830713. Inclusion in this directory is not an endorsement.